€ 20.65
Key Takeaways
Risk factor
Low price volatility
Profitability factor
Strong margins and returns
About
Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair val
Target Price
The average target price of FAGR.BR is 25 and suggests 23% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
